Henan Hui Run Pharmaceutical Co. , Ltd. is located in Zhengzhou Huiji District Dahe Road East section, convenient transportation, logistics developed. The company is mainly engaged in R & D, production, sales and import and export of animal drugs, pharmaceutical raw materials, pharmaceutical intermediates, feed additives and other products. The company has two production bases, which are located in Jiaozuo Bo'ai County industrial cluster and Luohe salt and chemical industrial park. The main API products are Carbasalate calcium, butaphos, aminophylline, Benýr, pralidoxime iodide, Pralidoxime, butaphos, Albendazole, phenolethylethylamine, ethylenediamine diacetoaminoacetate (xinningling) , inosine, sodium deoxynocarpine, water-soluble amoxicillin, inosine, praziquantel, methacholine chloride, atropine sulfate, sodium sulfamethoxine, sarafloxacin hydrochloride, acridine hydrochloride, sodium cyanoiosamide. The main pharmaceutical intermediates are: 4-aminobenzamidine dihydrochloride, 2,2-biphenol, Tropicone, α-nortropinol hydrochloride, isoprenin, N, n-dimethylisopropanolamine, 3, 5-diiodosalicylic acid, as well as new feed additives such as lysozyme, transfer factor, Adenosine triphosphate (ATP) and other products.
more >
Year of Establishment:
2013
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
All,Agent,Distributor,Trading Company,Retailer,Service Provider,Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: